|
covid-19 |
24 |
|
adult |
18 |
|
emergency department |
18 |
|
aged |
17 |
|
mortality |
12 |
|
stroke |
12 |
|
myocardial infarction |
11 |
|
adolescent |
10 |
|
humans |
9 |
|
emergency medicine |
8 |
|
emergency service, hospital |
8 |
|
intubation |
8 |
|
middle aged |
8 |
|
aged, 80 and over |
7 |
|
atrial fibrillation |
7 |
|
family well-being |
7 |
|
female |
7 |
|
health literacy |
7 |
|
heart failure |
7 |
|
hong kong |
7 |
|
information sharing |
7 |
|
male |
7 |
|
outcome |
7 |
|
preventive measures |
7 |
|
risk factors |
7 |
|
trauma |
7 |
|
all-cause mortality |
6 |
|
angiotensin receptor blockers |
6 |
|
angiotensinconverting enzyme inhibitors |
6 |
|
anxiety |
6 |
|
cancer |
6 |
|
cardiovascular mortality |
6 |
|
child |
6 |
|
child maltreatment |
6 |
|
covid-19 incidence |
6 |
|
depression symptom |
6 |
|
diabetes |
6 |
|
diabetes mellitus |
6 |
|
dipeptidyl peptidase-4 inhibitors |
6 |
|
income instability |
6 |
|
infection |
6 |
|
intensive care unit |
6 |
|
job loss |
6 |
|
mental health |
6 |
|
pandemic |
6 |
|
parenting |
6 |
|
prognosis |
6 |
|
severe acute respiratory syndrome - diagnosis |
6 |
|
sodium-glucose co-transporter |
6 |
|
sodium-glucose cotransporter-2 inhibitors |
6 |
|
stress |
6 |
|
triage |
6 |
|
vaccine |
6 |
|
validation |
6 |
|
vulnerable group |
6 |
|
acute kidney injury |
5 |
|
aerosol |
5 |
|
aerosol box |
5 |
|
antibiotic therapy |
5 |
|
antimicrobial activity |
5 |
|
bacterial gene |
5 |
|
cardiopulmonary resuscitation |
5 |
|
community mental health services |
5 |
|
confirmatory factor analysis |
5 |
|
cost of waiting |
5 |
|
decision making |
5 |
|
delay announcement |
5 |
|
hospital |
5 |
|
logistic models |
5 |
|
manikin, intubation tent |
5 |
|
medical education |
5 |
|
medical history taking |
5 |
|
myocarditis |
5 |
|
myopericarditis |
5 |
|
online interprofessional education |
5 |
|
pericarditis |
5 |
|
predictive value of tests |
5 |
|
psychiatric emergency admission |
5 |
|
queueing behavior |
5 |
|
queueing network coordination |
5 |
|
rapid sequence intubation |
5 |
|
resuscitation |
5 |
|
retrospective studies |
5 |
|
risk score |
5 |
|
safety |
5 |
|
seasonality |
5 |
|
sensitivity and specificity |
5 |
|
unemployment |
5 |
|
warfarin |
5 |
|
wounds and injuries |
5 |
|
2019 novel coronavirus disease |
4 |
|
algorithms |
4 |
|
big data |
4 |
|
blood pressure variability |
4 |
|
cardiac arrest |
4 |
|
chinese |
4 |
|
covid‐19 |
4 |
|
crew resource management |
4 |
|
early diagnosis |
4 |
|
edoxaban |
4 |
|
elderly |
4 |
|
electrocardiography |
4 |
|
epidemiology |
4 |
|
epinephrine |
4 |
|
fracture |
4 |
|
heart arrest |
4 |
|
injury |
4 |
|
metformin |
4 |
|
methamphetamine |
4 |
|
neurological outcome |
4 |
|
neutrophil-to-lymphocyte ratio |
4 |
|
osteoporotic |
4 |
|
plasma |
4 |
|
poisoning |
4 |
|
prediction |
4 |
|
predictive model |
4 |
|
risk stratification, dementia |
4 |
|
roc curve |
4 |
|
severe acute respiratory syndrome coronavirus 2 |
4 |
|
simulation |
4 |
|
subarachnoid hemorrhage |
4 |
|
sulphonylurea |
4 |
|
teamwork |
4 |
|
traumatic brain injury |
4 |
|
unprotected left |
4 |
|
young adult |
4 |
|
acute coronary syndrome |
3 |
|
alzheimer's disease |
3 |
|
ambulance |
3 |
|
china |
3 |
|
cognitive dysfunction |
3 |
|
community |
3 |
|
covid-19 pandemic |
3 |
|
critical illness |
3 |
|
curfew |
3 |
|
dementia |
3 |
|
deranged liver function |
3 |
|
diagnosis |
3 |
|
disasters |
3 |
|
dpp4 |
3 |
|
dpp4 inhibitor |
3 |
|
electronic health records |
3 |
|
emergency medical service |
3 |
|
hemodynamics |
3 |
|
hypoceruloplasminemia |
3 |
|
injuries |
3 |
|
lockdown |
3 |
|
maldi-tof ms |
3 |
|
multiple trauma |
3 |
|
national containment |
3 |
|
neurotoxicity |
3 |
|
older adults |
3 |
|
operations management |
3 |
|
parkinson's disease |
3 |
|
patient boarding |
3 |
|
physicians |
3 |
|
pneumonia |
3 |
|
polymorphism |
3 |
|
prevention |
3 |
|
reference values |
3 |
|
risk assessment |
3 |
|
severe acute respiratory syndrome |
3 |
|
sglt2 |
3 |
|
sglt2 (sodium-glucose cotransporter 2) inhibitor |
3 |
|
silver poisoning / intoxication |
3 |
|
socio-demographic characteristics |
3 |
|
spatial analysis |
3 |
|
staphylococcus lugdunensis |
3 |
|
stay-at-home |
3 |
|
substance-induced psychosis |
3 |
|
time series analysis |
3 |
|
trauma system |
3 |
|
urban geometry |
3 |
|
urinary tract infection |
3 |
|
wilson disease |
3 |
|
abdominal pain |
2 |
|
accident and emergency department |
2 |
|
accidental falls |
2 |
|
acupuncture |
2 |
|
acute appendicitis |
2 |
|
acute epiglottitis |
2 |
|
acute lung injury |
2 |
|
acute subdural hematoma |
2 |
|
adhesion molecules |
2 |
|
admissions |
2 |
|
adrenaline |
2 |
|
alleles |
2 |
|
allergic rhinitis |
2 |
|
ambulances |
2 |
|
amiodarone |
2 |
|
antibiotics |
2 |
|
apolipoprotein e |
2 |
|
apolipoprotein e4 |
2 |
|
apolipoproteins e - genetics |
2 |
|
attendances |
2 |
|
bias (epidemiology) |
2 |
|
blood chemical analysis - methods |
2 |
|
blood circulation |
2 |
|
blood component transfusion - standards |
2 |
|
blood specimen collection |
2 |
|
body weights and measures |
2 |
|
breathing rate |
2 |
|
bronchoscopy |
2 |
|
carcinoma, hepatocellular - blood - diagnosis |
2 |
|
cardiac arrhythmias |
2 |
|
cardiac output |
2 |
|
care |
2 |
|
case mix |
2 |
|
case report |
2 |
|
cell-adhesion |
2 |
|
cerebral contusion |
2 |
|
chest pain |
2 |
|
circulating nucleic acids |
2 |
|
clinical prediction rule |
2 |
|
coagulopathy |
2 |
|
cognitive impairment |
2 |
|
cohort studies |
2 |
|
computed tomography |
2 |
|
coronavirus |
2 |
|
craniotomy |
2 |
|
cricothyroidotomy |
2 |
|
critical care |
2 |
|
cross-sectional studies |
2 |
|
cross-sectional study |
2 |
|
cycle |
2 |
|
decision-making |
2 |
|
decompressive craniectomy |
2 |
|
demand |
2 |
|
designer drug |
2 |
|
diabetic ketoacidosis |
2 |
|
dimensional measurement accuracy |
2 |
|
dna, mitochondrial - blood |
2 |
|
doppler |
2 |
|
doppler ultrasonography |
2 |
|
echocardiography |
2 |
|
effectiveness |
2 |
|
emergency departments |
2 |
|
emergency medical services |
2 |
|
emergency preparedness |
2 |
|
emergency service |
2 |
|
emphysematous pyelonephritis |
2 |
|
erythrocyte transfusion |
2 |
|
erythrocyte transfusion - trends |
2 |
|
exons - genetics |
2 |
|
falls |
2 |
|
filtration |
2 |
|
flexible nasolaryngoscopy |
2 |
|
fresh-frozen plasma |
2 |
|
functional outcome |
2 |
|
functional outcomes |
2 |
|
gender |
2 |
|
general practitioners |
2 |
|
genotype |
2 |
|
glasgow coma scale |
2 |
|
glyceraldehyde-3-phosphate dehydrogenases - blood - genetics |
2 |
|
guidelines |
2 |
|
haemodynamics |
2 |
|
health planning |
2 |
|
hemorrhage - etiology - physiopathology - therapy |
2 |
|
hong kong - epidemiology |
2 |
|
hormonal |
2 |
|
hospital emergency service |
2 |
|
human |
2 |
|
indomethacin |
2 |
|
infant |
2 |
|
influenza |
2 |
|
intervention |
2 |
|
intracerebral haemorrhage |
2 |
|
intratracheal intubation |
2 |
|
ischemic |
2 |
|
ischemic stroke |
2 |
|
klebsiella pneumoniae |
2 |
|
l-selectin |
2 |
|
leucocytes |
2 |
|
linear models |
2 |
|
lipoprotein lipase |
2 |
|
lipoprotein lipase - genetics |
2 |
|
liver abscess |
2 |
|
liver neoplasms - blood - diagnosis |
2 |
|
lymphocytes |
2 |
|
mace |
2 |
|
massive transfusion |
2 |
|
matrix metalloproteinase 9 (mmp9) |
2 |
|
medical overuse |
2 |
|
mobile app |
2 |
|
model |
2 |
|
monocytes |
2 |
|
morbidity |
2 |
|
mortality rate |
2 |
|
musculoskeletal injury |
2 |
|
myocardial infarction - epidemiology - genetics |
2 |
|
neurological outcomes |
2 |
|
neurosurgery |
2 |
|
neutrophils |
2 |
|
novel psychoactive substances |
2 |
|
nurses |
2 |
|
online symptom checkers |
2 |
|
pain protocol |
2 |
|
patient |
2 |
|
patient satisfaction |
2 |
|
pharyngeal |
2 |
|
plasma dna |
2 |
|
polymerase chain reaction |
2 |
|
polymorphism, genetic |
2 |
|
predictors |
2 |
|
prehospital |
2 |
|
prehospital care |
2 |
|
primary health care |
2 |
|
professional education |
2 |
|
quality of life |
2 |
|
red blood cells |
2 |
|
reflex |
2 |
|
registries - statistics and numerical data |
2 |
|
regression analysis |
2 |
|
reliability and validity |
2 |
|
reproducibility of results |
2 |
|
resources |
2 |
|
respiratory distress syndrome |
2 |
|
resuscitation - methods |
2 |
|
reverse transcriptase polymerase chain reaction |
2 |
|
risk |
2 |
|
rna, messenger - blood |
2 |
|
seasons |
2 |
|
self-harm |
2 |
|
sensitivity |
2 |
|
sepsis |
2 |
|
shock, hemorrhagic - epidemiology - therapy |
2 |
|
smoking |
2 |
|
specificity |
2 |
|
stroke - epidemiology - genetics |
2 |
|
stroke volume |
2 |
|
suicidal ideation |
2 |
|
suicide |
2 |
|
support |
2 |
|
survival |
2 |
|
survivors |
2 |
|
synthetic cannabinoids |
2 |
|
thromboembolism |
2 |
|
thwarted belongingness |
2 |
|
time factor |
2 |
|
time factors |
2 |
|
toxicity |
2 |
|
transfusion |
2 |
|
trauma centers - organization and administration |
2 |
|
treatment |
2 |
|
treatment outcome |
2 |
|
triage analgesia |
2 |
|
triss |
2 |
|
ultracentrifugation |
2 |
|
ultrasonography |
2 |
|
ultrasound |
2 |
|
unconsciousness |
2 |
|
undergraduate medical education |
2 |
|
ventricular fibrillation |
2 |
|
volunteers |
2 |
|
weather |
2 |
|
wounds and injuries - blood - diagnosis |
2 |
|
wounds, nonpenetrating - diagnosis - epidemiology - therapy |
2 |
|
youth |
2 |
|
(mesh) pediatrics |
1 |
|
abdominal injuries |
1 |
|
abuse |
1 |
|
accident & emergency department offenders |
1 |
|
accident and emergency departments |
1 |
|
acetaminophen |
1 |
|
acidosis |
1 |
|
acute abdomen |
1 |
|
acute abdominal pain |
1 |
|
acute coronary syndrome (acs) |
1 |
|
acute interstitial |
1 |
|
acute kidney disease |
1 |
|
acute medicine |
1 |
|
acute myocardial infarction (ami) |
1 |
|
acute poisoning |
1 |
|
acute renal failure |
1 |
|
acute respiratory tract infections |
1 |
|
acute services |
1 |
|
adrenergic alpha-2 receptor agonist |
1 |
|
adult epiglottitis |
1 |
|
adults |
1 |
|
advanced life support |
1 |
|
adverse outcomes |
1 |
|
aetiology |
1 |
|
age distribution |
1 |
|
age factor |
1 |
|
age factors |
1 |
|
ageing |
1 |
|
agitation |
1 |
|
air insufflation |
1 |
|
airway management |
1 |
|
airway obstruction |
1 |
|
alcohol |
1 |
|
alcohol drinking |
1 |
|
alkaloid toxicity |
1 |
|
allergic reaction |
1 |
|
allergy |
1 |
|
anaphylactoid reactions |
1 |
|
anaphylaxis |
1 |
|
anticoagulation |
1 |
|
apache ii |
1 |
|
apls |
1 |
|
arachidonic acid metabolites |
1 |
|
arrhythmia |
1 |
|
arsenic |
1 |
|
asia |
1 |
|
aspiration |
1 |
|
asthenia |
1 |
|
asthma |
1 |
|
attitudes |
1 |
|
audit |
1 |
|
bacterial infection |
1 |
|
banach |
1 |
|
barcode-style |
1 |
|
barotrauma |
1 |
|
biphasic reaction |
1 |
|
blood flow |
1 |
|
blood pressure |
1 |
|
blood-brain barrier |
1 |
|
bodyweights and measures |
1 |
|
brain ischemia - enzymology - epidemiology - genetics |
1 |
|
c-reactive protein |
1 |
|
c-reactive protein (crp) |
1 |
|
cardiac |
1 |
|
cardiovascular accidents |
1 |
|
cardiovascular disease |
1 |
|
case-control studies |
1 |
|
catecholamine |
1 |
|
catecholamines |
1 |
|
cd62l |
1 |
|
cerebrovascular accident |
1 |
|
cervical spine trauma |
1 |
|
chest |
1 |
|
chest injury |
1 |
|
children |
1 |
|
chlamydophila |
1 |
|
chloroxylenol |
1 |
|
clinical decision unit |
1 |
|
clinical epidemiology |
1 |
|
clinical nephrology |
1 |
|
clinical prediction score |
1 |
|
clinical protocols |
1 |
|
clinical significance |
1 |
|
clinical trial |
1 |
|
co-morbidity |
1 |
|
colonoscopy |
1 |
|
color doppler |
1 |
|
colorectal cancer |
1 |
|
commercial aviation |
1 |
|
comorbidity |
1 |
|
comparative study |
1 |
|
compliance |
1 |
|
concussion |
1 |
|
confidentiality |
1 |
|
considerations |
1 |
|
corticosteroid |
1 |
|
cost-effectiveness |
1 |
|
coxassociated metabolites |
1 |
|
crack cocaine |
1 |
|
critical condition |
1 |
|
crp |
1 |
|
ct |
1 |
|
cyclic-amp |
1 |
|
cyclonic storms |
1 |
|
d-dimer |
1 |
|
decision curve analysis |
1 |
|
defibrillation |
1 |
|
defibrillator |
1 |
|
diagnostic imaging |
1 |
|
diagnostic radiology |
1 |
|
diagnostic techniques and procedures |
1 |
|
diclofenac |
1 |
|
diffusion |
1 |
|
diffusion-weighted imaging |
1 |
|
disaster preparedness |
1 |
|
disinfectants/poisoning |
1 |
|
dizziness |
1 |
|
doppler spectrum |
1 |
|
drug administration |
1 |
|
drug overdose |
1 |
|
drug therapy |
1 |
|
drug toxicity |
1 |
|
dwi |
1 |
|
ecg |
1 |
|
egfr protein, human |
1 |
|
eicosanoids |
1 |
|
electrocardiogram |
1 |
|
electrolytes |
1 |
|
embolism |
1 |
|
emergencies |
1 |
|
emergency department triage |
1 |
|
emergency medical system |
1 |
|
emergency nursing |
1 |
|
emergency services |
1 |
|
emerging infectious diseases |
1 |
|
ems |
1 |
|
endocarditis |
1 |
|
enteral nutrition |
1 |
|
epidemiology and outcomes |
1 |
|
equestrian |
1 |
|
equipment design |
1 |
|
ethnicity |
1 |
|
evacuation |
1 |
|
external chest compression |
1 |
|
extradural haematoma |
1 |
|
falls reduction |
1 |
|
fast scale |
1 |
|
fatal outcome |
1 |
|
fever |
1 |
|
flexible laryngoscopy |
1 |
|
folate |
1 |
|
followership |
1 |
|
frail elderly |
1 |
|
frailty |
1 |
|
gastroenteritis |
1 |
|
general anaesthesia |
1 |
|
geriatrics |
1 |
|
glasgow coma score |
1 |
|
glasgow outcome scale |
1 |
|
global registry for acute coronary event |
1 |
|
glutathione |
1 |
|
gout |
1 |
|
gps spatial sampling |
1 |
|
granulocytes (mesh terms) |
1 |
|
guangzhou |
1 |
|
guanine adenine thymine adenine sequence-binding protein (gata3) |
1 |
|
h1n1 |
1 |
|
head |
1 |
|
head injury |
1 |
|
health care workers |
1 |
|
health knowledge |
1 |
|
health policy |
1 |
|
health service research |
1 |
|
health services research |
1 |
|
health status |
1 |
|
heart |
1 |
|
heart diseases |
1 |
|
heart function test |
1 |
|
heart score |
1 |
|
helical ct |
1 |
|
hemorrhage |
1 |
|
hemorrhagic stroke |
1 |
|
herbal medicine |
1 |
|
high-risk |
1 |
|
high-sensitivity c-reactive protein (hs-crp) |
1 |
|
home visit |
1 |
|
homocysteine - metabolism |
1 |
|
hs-ctnt |
1 |
|
human immunodeficiency virus |
1 |
|
hyperacute infarct |
1 |
|
hypertension |
1 |
|
hypertension diagnosis |
1 |
|
hypertension screening |
1 |
|
icu |
1 |
|
immersion hypothermia |
1 |
|
immobilization |
1 |
|
incidence |
1 |
|
infection control |
1 |
|
infectious diarrhea |
1 |
|
inflammation |
1 |
|
inhalation |
1 |
|
injury prevention |
1 |
|
intelligence |
1 |
|
international ems systems |
1 |
|
intratracheal |
1 |
|
investigation for hypertension |
1 |
|
ischaemic heart disease |
1 |
|
kidney |
1 |
|
knee |
1 |
|
lactate |
1 |
|
lapss scale |
1 |
|
laryngoscopy |
1 |
|
lateral flow assay |
1 |
|
leadership development |
1 |
|
learning curve |
1 |
|
legislation |
1 |
|
length of stay |
1 |
|
leukocytes |
1 |
|
limb injury |
1 |
|
lipocalin-2 (lcn2) |
1 |
|
lower respiratory tract infection (lrti) |
1 |
|
lung |
1 |
|
machine learning |
1 |
|
magnetic resonance |
1 |
|
magnetic resonance imaging |
1 |
|
major adverse cardiac event |
1 |
|
major trauma |
1 |
|
maximum velocity estimation |
1 |
|
mca stenosis |
1 |
|
mdct |
1 |
|
medical diversions |
1 |
|
medical student |
1 |
|
medical volunteers |
1 |
|
medicinal plants |
1 |
|
messenger rna (mrna) |
1 |
|
methylenetetrahydrofolate reductase (mthfr) |
1 |
|
methylenetetrahydrofolate reductase (nadph2) - genetics - metabolism |
1 |
|
mice |
1 |
|
microfluidics |
1 |
|
microrna |
1 |
|
molecular diagnostics |
1 |
|
mortality prediction |
1 |
|
mrna |
1 |
|
multiple organ dysfunction syndrome |
1 |
|
multiple organ dysfunction syndrome (mods) |
1 |
|
multiple organ failure |
1 |
|
mutation |
1 |
|
mycoplasma |
1 |
|
myeloperoxidase (mpo) |
1 |
|
nasogastric tube |
1 |
|
nasopharyngeal cancer |
1 |
|
natural disaster |
1 |
|
neopterin |
1 |
|
nihss |
1 |
|
non-prescription drugs |
1 |
|
nonpenetrating wounds |
1 |
|
nonsteroidal anti-inflammatory drug |
1 |
|
nonsteroidal antiinflammatory drugs |
1 |
|
normal ranges |
1 |
|
nsaid |
1 |
|
nucleic acids |
1 |
|
nurse clinicians |
1 |
|
nurse practitioner |
1 |
|
nurse practitioners |
1 |
|
nurse's role |
1 |
|
observation |
1 |
|
observation ward |
1 |
|
occult pneumothorax |
1 |
|
occupational risk |
1 |
|
occupational therapy |
1 |
|
odds ratio |
1 |
|
opioids |
1 |
|
organ failure (of) |
1 |
|
oscillometric |
1 |
|
osteoarthritis |
1 |
|
outcomes |
1 |
|
overdose |
1 |
|
paediatrics |
1 |
|
pain |
1 |
|
pain score |
1 |
|
pandemic vaccine |
1 |
|
paramedic |
1 |
|
paramedic activities |
1 |
|
paramedics |
1 |
|
paraoxonase |
1 |
|
patient admission |
1 |
|
patient experience |
1 |
|
patient positioning |
1 |
|
patient recruitment challenges |
1 |
|
patients and staff |
1 |
|
pedestrian |
1 |
|
pediatrics |
1 |
|
peds score |
1 |
|
performance |
1 |
|
perfusion |
1 |
|
physiologic monitoring |
1 |
|
plasma rna |
1 |
|
plasma β-globin dna |
1 |
|
platelet |
1 |
|
pneumoperitoneum |
1 |
|
pneumothorax |
1 |
|
poc |
1 |
|
police |
1 |
|
position |
1 |
|
positive end-expiratory pressure |
1 |
|
post-stroke modified rankin score |
1 |
|
posttraumatic |
1 |
|
practice |
1 |
|
predicted vo 2max |
1 |
|
prediction rules |
1 |
|
predictive |
1 |
|
prednisolone |
1 |
|
preschool |
1 |
|
preschool child |
1 |
|
prevention and control |
1 |
|
primary care streaming |
1 |
|
procalcitonin |
1 |
|
professional autonomy |
1 |
|
prognostic |
1 |
|
prognostic biomarker |
1 |
|
prospective studies |
1 |
|
psychological services utility |
1 |
|
pulmonary embolism |
1 |
|
pupils |
1 |
|
pyrrolidonecarboxylic acid |
1 |
|
qualitative research |
1 |
|
quality control |
1 |
|
radiation doses |
1 |
|
radiography |
1 |
|
radiological classification |
1 |
|
ramped position |
1 |
|
randomised controlled trial |
1 |
|
realgar |
1 |
|
receptor, epidermal growth factor |
1 |
|
recurrence |
1 |
|
reference standard |
1 |
|
referral for hypertension |
1 |
|
registries |
1 |
|
risk factor |
1 |
|
risk stratification |
1 |
|
rosier scale |
1 |
|
s100 protein |
1 |
|
sars |
1 |
|
sars virus |
1 |
|
score |
1 |
|
screening |
1 |
|
sedation |
1 |
|
seizure |
1 |
|
self-efficacy |
1 |
|
semi-quantitative |
1 |
|
sensitivity analysis |
1 |
|
serotonin syndrome |
1 |
|
severe sepsis |
1 |
|
severity |
1 |
|
sex |
1 |
|
sex distribution |
1 |
|
sex factors |
1 |
|
short stay unit |
1 |
|
short-form 36 |
1 |
|
sibutramine |
1 |
|
skin diseases |
1 |
|
small subcortical infarcts |
1 |
|
spectral envelope estimation |
1 |
|
sphygmomanometer |
1 |
|
spinal board |
1 |
|
sporting injuries |
1 |
|
standardized questionnaire |
1 |
|
stool culture |
1 |
|
stress hormones |
1 |
|
stroke - enzymology - genetics |
1 |
|
stroke mimics |
1 |
|
study |
1 |
|
supine position |
1 |
|
surveys and questionnaires |
1 |
|
syncope |
1 |
|
t-box expressed in t cells (tbet) |
1 |
|
taiwan |
1 |
|
team building |
1 |
|
thoracostomy |
1 |
|
thrombolysis in myocardial infarction |
1 |
|
thrombolytic therapy |
1 |
|
thrombosis |
1 |
|
timi |
1 |
|
timi score |
1 |
|
tomography x-ray computed |
1 |
|
toxic plants |
1 |
|
toxicology |
1 |
|
trachea manometry |
1 |
|
tracheal |
1 |
|
tramadol |
1 |
|
transfusion - trauma |
1 |
|
transfusion strategy |
1 |
|
transthoracic echocardiography |
1 |
|
trauma centre |
1 |
|
trauma diversion |
1 |
|
trauma epidemiology |
1 |
|
trauma management |
1 |
|
trauma nurse coordinator |
1 |
|
trauma registry |
1 |
|
trauma systems |
1 |
|
trauma team |
1 |
|
trauma team leader |
1 |
|
treatment outcomes |
1 |
|
troponin |
1 |
|
tuberculosis |
1 |
|
turbulence |
1 |
|
urgent care |
1 |
|
vaccination |
1 |
|
vertigo |
1 |
|
vital signs |
1 |
|
wounds |
1 |
|
wrist device |
1 |
|
x-ray |
1 |
